atum logo
image/svg+xml

Tools and Solutions for
the Life Sciences

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need expression optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need expression optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

Expert
Guidance

We think of projects more as a collaboration than services. We aim to combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and codon optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.

Call

Corporate Headquarters
(Newark, California)
+1 650 853 8347

Email

We generally reply within a few hours.

info@atum.bio

Atum
in the World

May 12-15 2020

ASGCT 23rd Annual Meeting - CANCELLED

Boston, MA
ATUM will exhibit at booth #1102
May 20-21 2020

NIH Spring Biomedical Research Festival - CANCELLED

Bethesda, MD
ATUM will exhibit
June 8-11 2020

BIO International Convention

San Diego, CA
ATUM will exhibit at booth #1604
June 08-10 2020

4th ISPMF Conference - CANCELLED

Rome, Italy
ATUM's Claes Gustafsson will present, time TBA
July 13-16 2020

Cell Line Development and Engineering (BPI) Europe

Amsterdam, The Netherlands
ATUM will present and exhibit at booth #107
August 11-13 2020

Cell Line Development and Engineering (BPI West) US

Santa Clara, CA
ATUM will present and exhibit
August 25-27 2020

Bispecific Antibody Pipeline Congress - CANCELLED

Washington DC
ATUM will present and exhibit at booth #7
August 25-27 2020

Antibody Engineering & Therapeutics Europe

Amsterdam, The Netherlands
ATUM will present and exhibit at stand #16
August 27-28 2020

13th Annual Proteins & Antibodies Congress

London, UK
ATUM's Claes Gustafsson will present on August 28 at 11:50 am and exhibit at space #13
August 31-September 4 2020

PEGS Boston POSTPONED-new date Aug 31

Boston, MA
ATUM will present and exhibit at booth #407
September 9-10 2020

Protein Engineering Congress USA

San Jose, CA
ATUM will present and exhibit
November 3-4 2020

9th Annual Cell Line Development & Engineering Asia - POSTPONED to Nov

Shanghai, China
ATUM will present and exhibit at booth #21
2020-03-19

Coronavirus Special: Dr John Ioannadis: 'Minimal evidence, monumental decisions'

2020-03-19

Some Progress Made in Push to Find Coronavirus Treatment

2020-03-02

Bay Area Tech Companies Look for Coronavirus Treatment

2020-02-18

Leap into Efficient Cell Lines

2019-09-03

Leap-In Transposases and Transposons Accelerate Cell Line Development

2020-04-20

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

2020-03-25

ATUM Provides COVID-19 Diagnostic and Therapeutic Developers Free Access to its Protein Synthesis Platform

2019-06-11

ATUM Completes Transition to 100% Renewable Electricity for State-of-the-Art Bioproduction Facility

2019-05-28

ATUM Licenses Exclusive Access to Proprietary Gene-Coding Algorithm for Plant-Based Recombinant Protein Expression to Medicago

2019-01-14

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

`